Office of National Drug Control Policy
Executive Office of the President, Washington, DC 20503
Phone, 202-395-6700. Fax, 202-395-6708. Internet, www.whitehousedrugpolicy.gov.
Director of National Drug Control Policy John P. Walters
Chief of Staff Christopher M. Marston
Executive Secretary Virlena Cooper-Briscoe
Deputy Director Mary Ann Solberg
Deputy Director for Demand Reduction Andrea Grubbs Barthwell
Deputy Director for State and Local Affairs Scott M. Burns
Deputy Director for Supply Reduction Barry D. Crane
Associate Director, Planning and Budget Robert B. Eiss
Associate Director, Legislative Affairs Christine Morden
Associate Director, Management and Michele C. Marx
Communications Director Thomas A. Riley
General Counsel Edward H. Jurith
Director, Counter-Drug Technology Assessment Albert Brandenstein
Associate Director, Intelligence Roger Mackin
Associate Director, National Youth Anti-Drug Alan Levitt
Director, High-Intensity Drug Trafficking Areas Kurt Schmid
Administrator, Drug-Free Communities Support Gregory Dixon
The Office of National Drug Control Policy assists the President in establishing policies, priorities, and objectives in the National Drug Control Strategy. It also provides budget, program, and policy recommendations on the efforts of National Drug Control Program agencies.
The Office of National Drug Control Policy was established by the National Narcotics Leadership Act of 1988 (21 U.S.C. 1501 et seq.), effective January 29, 1989, as amended by the Violent Crime Control and Law Enforcement Act of 1994 (21 U.S.C. 1502, 1506, 1508) and reauthorized by the Office of National Drug Control Policy Reauthorization Act of 1988 (21 U.S.C. 1701, et seq.).
The Director of National Drug Control Policy is appointed by the President with the advice and consent of the Senate. The Director is assisted by a Deputy Director, a Deputy Director for Demand Reduction, a Deputy Director for Supply Reduction, and a Deputy Director for State and Local Affairs.
The Director of National Drug Control Policy is responsible for establishing policies, objectives, priorities, and performance measurement for the national drug control program, and for annually promulgating a national drug control strategy and supporting annual reports and an annual national drug control program budget to be submitted to the Congress by the...